Novel mutations in HTRA1-related cerebral small vessel disease and comparison with CADASIL

Ann Clin Transl Neurol. 2022 Oct;9(10):1586-1595. doi: 10.1002/acn3.51654. Epub 2022 Sep 1.

Abstract

Objective: There is evidence showing both heterozygous HTRA1 and homozygous HTRA1 mutations as causal for familial cerebral small vessel disease (CSVD). The clinical and neuroimaging signs of heterozygous HTRA1-related CSVD can mimic cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL). We aimed to characterize the genotypic and phenotypic features of HTRA1-related CSVD, and we compared the features of heterozygous HTRA1-related CSVD and CADASIL.

Methods: We carried out genetic sequencing in a series of unrelated patients with suspected familial CSVD from China. Clinical and imaging characteristics of heterozygous HTRA1-related CSVD and CADASIL were compared.

Results: We identified nine heterozygous HTRA1 mutations and one homozygous HTRA1 mutation, seven of which are novel. Compared with CADASIL, patients with heterozygous HTRA1-related CSVD had a higher proportion of spine disorders and a lower proportion of white matter hyperintensities involving the anterior temporal lobe (p < 0.001).

Interpretation: This study shows that most HTRA1-related CSVD patients in China carry heterozygous HTRA1 mutations. The specific extra-neurological features and neuroimaging features reveal informative differences between heterozygous HTRA1-related CSVD and CADASIL. We expand the mutational spectrum of HTRA1.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • CADASIL* / diagnostic imaging
  • CADASIL* / genetics
  • Cerebral Small Vessel Diseases* / diagnostic imaging
  • Cerebral Small Vessel Diseases* / genetics
  • Heterozygote
  • High-Temperature Requirement A Serine Peptidase 1* / genetics
  • Humans
  • Mutation

Substances

  • High-Temperature Requirement A Serine Peptidase 1
  • HTRA1 protein, human

Grants and funding

This work was funded by Beijing Municipal Science and Technology Commission grant Z171100001017080.